Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Conditions: BCLC Stage C Hepatocellular Carcinoma; Chemotherapy Effect Interventions: Drug: intravenous FOLFOX7 plus Camrelizumab and apatinib; Drug: HAIC-FOLFOX plus Camrelizumab and apatinib Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials